Pfizer Results May Temper Efforts for Shakeup Demanded by Activist Investor

Key TakeawaysPfizer beat third-quarter profit and sales forecasts and raised its guidance on strong sales of its COVID-19 treatment.However, shares declined as the results may have put a damper on possible changes to the company demanded by activist investor Starboard Value.CEO Albert Bourla expressed confidence in the way Pfizer is executing its strategy. Shares of Pfizer (PFE) fell Tuesday as a strong earnings report is seen as likely to limit activist investor Starboard Value from driving major changes a ...